Cargando…

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine

Acute myeloid leukemia (AML) is a highly heterogeneous cancer of the hematopoietic system with no cure for most patients. In addition to chemotherapy, treatment options for AML include recently approved therapies that target proteins with roles in AML pathobiology, such as FLT3, BLC2, and IDH1/2. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casado, Pedro, Cutillas, Pedro R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152134/ https://www.ncbi.nlm.nih.gov/pubmed/36805445 http://dx.doi.org/10.1016/j.mcpro.2023.100517

Ejemplares similares

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

Explainable artificial intelligence for precision medicine in acute myeloid leukemia
por: Gimeno, Marian, et al.
Publicado: (2022)

Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
por: Kansal, Rina
Publicado: (2016)

Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010)

A precision medicine classification for treatment of acute myeloid leukemia in older patients
por: Mims, Alice S., et al.
Publicado: (2021)

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
por: Malani, Disha, et al.
Publicado: (2022)

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
por: Kramer, Michael H., et al.
Publicado: (2022)

Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells
por: Akhtar, Nosheen, et al.
Publicado: (2020)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
por: Pourrajab, Fatemeh, et al.
Publicado: (2020)

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
por: Lee, Su-In, et al.
Publicado: (2018)

Precision medicine in acute lymphoblastic leukemia
por: Pui, Ching-Hon
Publicado: (2020)

Personalized Proteomics: The Future of Precision Medicine
por: Duarte, Trevor T., et al.
Publicado: (2016)

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
por: Casado, Pedro, et al.
Publicado: (2018)

Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine
por: Wang, Han, et al.
Publicado: (2022)

Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
por: Miyamoto, Kenichi, et al.
Publicado: (2019)

Application of nanomaterials in proteomics-driven precision medicine
por: Zhang, Yong, et al.
Publicado: (2022)

Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia
por: Aasebø, Elise, et al.
Publicado: (2020)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
por: Sugita, Mayumi, et al.
Publicado: (2021)

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017)

Characterization of a TiO(2) enrichment method for label-free quantitative phosphoproteomics
por: Montoya, Alex, et al.
Publicado: (2011)

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Cluzeau, Thomas, et al.
Publicado: (2021)

Precision Medicine Management of Chronic Lymphocytic Leukemia
por: Moia, Riccardo, et al.
Publicado: (2020)

Characterization of TRKA signaling in acute myeloid leukemia
por: Herbrich, Shelley M., et al.
Publicado: (2018)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021)

The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives
por: Hernandez-Valladares, Maria, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

Male Infertility, Precision Medicine and Systems Proteomics
por: Agharezaee, Niloofar, et al.
Publicado: (2018)

Long Noncoding RNAs in Acute Myeloid Leukemia: Functional Characterization and Clinical Relevance
por: Gourvest, Morgane, et al.
Publicado: (2019)

Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia
por: Schoof, Erwin M., et al.
Publicado: (2016)

Checkpoint Inhibitors in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2023)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019)

miRNAs in acute myeloid leukemia
por: Liao, Qiong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2jfpsbbdtnbuq2gscttt3boke2